Though the incidence of early-onset neonatal group B streptococci (GBS) infection is relatively low, it remains a significant diagnosis because of its pernicious consequences. Treatment measures have been directed at antepartum, intrapartum, and neonatal patients in an effort to reduce GBS infections. Neonatal nurses must monitor infants at risk closely and be prepared to act to minimize impact of GBS.